2-es típusú cukorbetegség: vizsgálatok itt: Ukrajna
5 trials · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.
- 3. fázisNot yet taking people in UkrajnaA Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
- Where
- Chernivtsi, Ivano-Frankivsk, Kiev, Kyiv, Lviv, Uzhhorod, Vinnytsia
- Életkor
- 45 év to 64 év
- People
- 3000 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07900633 · EU 2026-525919-14-00 - 3. fázisTaking peopleA Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Where
- Kyiv, Lviv, Uzhhorod, Vinnytsia
- Életkor
- 18 év and over
- People
- 2000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07662109 · EU 2025-523941-81-00 - No phaseTaking peopleDIabetes GLycemic Assessment in Newly Confirmed Episodes
- Where
- Kyiv
- Életkor
- 18 év and over
- People
- 80
- Run by
- Nazarii Kobyliak
See details and how to joinNCT07690163 - No phaseTaking peopleiCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases
- Where
- Dnipro, Kharkiv, Kyiv, Lutsk, Uzhhorod, Vinnytsia, Zaporizhzhya
- Életkor
- 18 év and over
- People
- 35 000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT03549754 - 3. fázisTaking peopleA Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
- Where
- Kyiv, Lviv, Vinnytsia
- Életkor
- 18 év and over
- People
- 900 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07662135 · EU 2025-523940-12-00